Evaluating hospital costs in type 2 diabetes care: Does the choice of the model matter?

Current Medical Research and Opinion

Volumn 22, Issue 10, 2006, Pages 1965-1971

  Gregori, D ^a   Pagano, E ^a   Rosato, R ^a   Bo, S ^b   Zigon, G ^c   Merletti, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cost and cost analysis; Diabetes mellitus; Hospitalisation; Survival analysis

Indexed keywords

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH ECONOMICS; HOSPITAL CARE; HOSPITAL COST; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; STATISTICAL ANALYSIS;

ADULT; AGED; COST OF ILLNESS; COSTS AND COST ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; ITALY; MALE; MIDDLE AGED; MODELS, STATISTICAL;

EID: 33750532528     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X132550     Document Type: Conference Paper

References (24)

1. O'Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003;25:1017-38
2. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major comorbidity in people with diabetes mellitus. Can Med Assoc J 2003;168:1661-7
3. O'Brien JA, Patrick AR, Caro JJ. Cost of managing complications resulting from type 2 diabetes mellitus in Canada. Br Med Council Health Serv Res 2003;3:7
4. Norlund A, Apelqvist J, Bitzen PO, et al. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 2001;250:57-65
5. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002;45:S13-S17
6. Bo S, Ciccone G, Grassi G, et al. Patients with type 2 diabetes had higher rates of hospitalization than the general population. J Clin Epidemiol 2004;57:1196-201
7. Carral F, Olveira G, Salas J, et al. Care resource utilization and direct costs incurred by people with diabetes in a Spanish hospital. Diabetes Res Clin Pract 2002;56:27-34
8. Jonsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia 2002;45:S5-S12
9. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004;22:149-64
10. Gilmer TP, O'Connor PJ, Rush WA, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005;28:59-64
11. Brandle M, Zhou H, Smith BR, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003;26:2300-4
12. Morsanutto A, Berto P, Lopatriello S, et al. Major diabetes complications have an impact on total annual medical cost of type 2 diabetes. Diabetes Care 2004;27:1841-2
13. Ray JA, Valentine WJ, Secnik K, et al. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain. Curr Med Res Opin 2005;21:1617-29
14. Zhang P, Engelgau MM, Norris SL, et al. Application of economic analysis to diabetes and diabetes care. Ann Intern Med 2004;140:972-7
15. Dudley RA, Harrell Jr FE, Smith LR, et al. Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. J Clin Epidemiol 1993;46:261-71
16. Gray A, Fenn P, McGuire A. The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales. Diabetic Med 1995;12:1068-76
17. Fenn P, McGuire A, Backhouse M, Jones D. Modelling programme costs in economic evaluation. J Health Econ 1996;15:115-25
18. Etzioni RD, Feuer EJ, Sullivan SD, et al. On the use of survival analysis techniques to estimate medical care costs. J Health Econ 1999;18:365-80
19. Lipscomb J, Ancukiewicz M, Parmigiani G, et al. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making 1998;18(Suppl 2):S39-S56
20. Aalen OO. A linear regression model for the analysis of life times. Stat Med 1989;8:907-25
21. Aalen OO. Further results on the non-parametric linear regression model in survival analysis. Stat Med 1993;12:1569-88
22. Schemper M, Stare J. Explained variation in survival analysis. Stat Med 1996;15:1999-2012
23. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating medical costs from incomplete follow-up data. Biometrics 1997;53:419-34
24. Bang H, Tsiatis AA. Estimating medical cost with censored data. Biometrika 2000;2:329-43